OUL35

CAS No. 6336-34-1

OUL35( NSC39047 )

Catalog No. M24643 CAS No. 6336-34-1

OUL35 is a selective PARP-10 inhibitor, and small-molecule ARTD10 inhibitor. OUL35 has been shown to rescue cells from ARTD10-induced cell death.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 33 In Stock
5MG 29 In Stock
10MG 48 In Stock
25MG 95 In Stock
50MG 147 In Stock
100MG 228 In Stock
200MG 339 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    OUL35
  • Note
    Research use only, not for human use.
  • Brief Description
    OUL35 is a selective PARP-10 inhibitor, and small-molecule ARTD10 inhibitor. OUL35 has been shown to rescue cells from ARTD10-induced cell death.
  • Description
    OUL35 is a selective PARP-10 inhibitor, and small-molecule ARTD10 inhibitor. OUL35 has been shown to rescue cells from ARTD10-induced cell death.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NSC39047
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    PARP
  • Recptor
    ARTD10|PARP10
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    6336-34-1
  • Formula Weight
    256.26
  • Molecular Formula
    C14H12N2O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    C1=CC(=CC=C1C(=O)N)OC2=CC=C(C=C2)C(=O)N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Tripathi P , Tian Y M , Komnig D . The mono-ADP-ribosyltransferase ARTD10 regulates the voltage-gated K+ channel Kv1.1 through protein kinase C delta[J]. BMC Biology, 2020.
molnova catalog
related products
  • TIQ-A

    TIQ-A is a PARP1 inhibitor which involved in DNA single-strand break repair via the base excision repair pathway. PARP1 is triggered by DNA damage and its excessive activation has been proposed as a causative factor in many pathological conditions including ischemia and reperfusion injury, asthma-related inflammation, and atherogenesis.

  • BSI-201

    BSI-201 (Iniparib;NSC 746045;IND-71677;SAR240550) is a potent, small molecule PARP1 inhibitor with strong anti-neoplastic effect.

  • Gemcabene calcium

    Gemcabene (PD-72953, PD72953) is a first-in-class lipid-lowering agent and activator of PARP.